The abstract is read at the publisher; the summary is JClub's.
AIO, an interpretable multimodal ADMET framework for macrocycles and cyclic peptides, achieves Pearson R = 0.87 for PAMPA permeability and AUROC = 0.91 for bioavailability.
- Why it matters: ADMET prediction is hard for bRo5 cyclic scaffolds because data are sparse, conformations depend on environment, and topology complicates modeling.
- What they did: AIO uses topology-preserving molecular segmentation plus solvent-aware contrastive pretraining, then evaluates performance with repeated cross-validation across multiple ADMET endpoints.
- The result: Predictions match reported pharmacokinetic profiles in case studies of recently approved macrocyclic and cyclic-peptide drugs, and segment-level attribution pinpoints regions linked to predicted ADMET bottlenecks.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.